Correlation Between Eyepoint Pharmaceuticals and Wave Life

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Eyepoint Pharmaceuticals and Wave Life at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Eyepoint Pharmaceuticals and Wave Life into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Eyepoint Pharmaceuticals and Wave Life Sciences, you can compare the effects of market volatilities on Eyepoint Pharmaceuticals and Wave Life and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Eyepoint Pharmaceuticals with a short position of Wave Life. Check out your portfolio center. Please also check ongoing floating volatility patterns of Eyepoint Pharmaceuticals and Wave Life.

Diversification Opportunities for Eyepoint Pharmaceuticals and Wave Life

0.73
  Correlation Coefficient

Poor diversification

The 3 months correlation between Eyepoint and Wave is 0.73. Overlapping area represents the amount of risk that can be diversified away by holding Eyepoint Pharmaceuticals and Wave Life Sciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Wave Life Sciences and Eyepoint Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Eyepoint Pharmaceuticals are associated (or correlated) with Wave Life. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Wave Life Sciences has no effect on the direction of Eyepoint Pharmaceuticals i.e., Eyepoint Pharmaceuticals and Wave Life go up and down completely randomly.

Pair Corralation between Eyepoint Pharmaceuticals and Wave Life

Given the investment horizon of 90 days Eyepoint Pharmaceuticals is expected to under-perform the Wave Life. In addition to that, Eyepoint Pharmaceuticals is 1.05 times more volatile than Wave Life Sciences. It trades about -0.25 of its total potential returns per unit of risk. Wave Life Sciences is currently generating about 0.02 per unit of volatility. If you would invest  1,499  in Wave Life Sciences on August 29, 2024 and sell it today you would earn a total of  0.00  from holding Wave Life Sciences or generate 0.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Eyepoint Pharmaceuticals  vs.  Wave Life Sciences

 Performance 
       Timeline  
Eyepoint Pharmaceuticals 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Eyepoint Pharmaceuticals are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Eyepoint Pharmaceuticals unveiled solid returns over the last few months and may actually be approaching a breakup point.
Wave Life Sciences 

Risk-Adjusted Performance

13 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Wave Life Sciences are ranked lower than 13 (%) of all global equities and portfolios over the last 90 days. In spite of rather weak basic indicators, Wave Life exhibited solid returns over the last few months and may actually be approaching a breakup point.

Eyepoint Pharmaceuticals and Wave Life Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Eyepoint Pharmaceuticals and Wave Life

The main advantage of trading using opposite Eyepoint Pharmaceuticals and Wave Life positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Eyepoint Pharmaceuticals position performs unexpectedly, Wave Life can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Wave Life will offset losses from the drop in Wave Life's long position.
The idea behind Eyepoint Pharmaceuticals and Wave Life Sciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Commodity Directory
Find actively traded commodities issued by global exchanges
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk